Portland, ORNCT05906316Now EnrollingIRB Ready

Mycobacterium Avium Complex Pulmonary Disease Clinical Trial in Portland, OR

Access cutting-edge mycobacterium avium complex pulmonary disease treatment through this clinical trial at a research site in Portland. Study-provided care at no cost to qualified participants.

Sponsored by Radboud University Medical Center

Quick Self-Assessment

See if you qualify for this Portland location

Preparing your pre-screening questions…

Expert Care in Portland

Access mycobacterium avium complex pulmonary disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related mycobacterium avium complex pulmonary disease treatment provided free

Apply for This Portland Location

Check if you qualify for this mycobacterium avium complex pulmonary disease clinical trial in Portland, OR

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Portland

    Convenient for OR residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Portland site if eligible
  4. 4Begin participation

About This Mycobacterium Avium Complex Pulmonary Disease Study in Portland

To gain insight in the effectiveness of, adherence and adjustments to guideline-based three-drug antimycobacterial therapy in patients with Mycobacterium avium complex pulmonary disease (MAC-PD) during the first 6 months of treatment.

Sponsor: Radboud University Medical Center

Who Can Participate

Inclusion Criteria

Newly diagnosed MAC-PD (primary or recurrent) as per the international NTM guideline that requires three-drug antimycobacterial treatment
Signed and dated informed consent

Exclusion Criteria

The participant is in poor general condition where participation in the study cannot be accepted per discretion of the Investigator
The participant has a known or suspected, current drug or alcohol abuse, that is, in the opinion of the Investigator, sufficient to compromise the safety or cooperation of the patient
HIV-infection;
Cystic fibrosis;
\>1 month antibiotic treatment for current MAC infection;
\< 6 months between previous antimycobacterial NTM-PD treatment and antimycobacterial treatment for current MAC-PD
Disseminated MAC infection;
Active pulmonary tuberculosis, fungal or nocardial disease requiring treatment;
Active pulmonary malignancy (primary or metastatic) or any other malignancy requiring chemotherapy or radiotherapy within 6 months before screening or anticipated during the study period;

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Portland?

Yes, this clinical trial (NCT05906316) has an active research site in Portland, OR that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Mycobacterium Avium Complex Pulmonary Disease Treatment Options in Portland, OR

If you're searching for mycobacterium avium complex pulmonary disease treatment options in Portland, OR, this clinical trial (NCT05906316) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Portland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced mycobacterium avium complex pulmonary disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all mycobacterium avium complex pulmonary disease clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Portland, OR

See all ankylosing spondylitis clinical trials recruiting in Portland — not just this study.

Browse Ankylosing Spondylitis Trials in Portland

Ready to Join in Portland?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Portland, OR